This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
D. Aarsland , K. Andersen , J. P. Larsen , A. Lolk and P. Kragh-Sorensen (2003). Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study. Archives of Neurology, 60, 387–392.
A. Antonini (2003). 123I-Ioflupane/SPECT binding to striatal dopamine transporter (DAT) uptake in patients with Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy. Neurological Science, 24, 149–150.
C. Ballard (2006). Differences in neuropathologic characteristics across the Lewy body dementia spectrum. Neurology, 67, 1931–1934.
H. Braak , T. K. Del , U. Rub , R. A. de Vos , E. N. Jansen Steur and E. Braak (2003). Staging of brain pathology related to sporadic Parkinson's disease. Neurobiology of Aging, 24, 197–211.
D. J. Burn , G. V. Sawle and D. J. Brooks (1994). Differential diagnosis of Parkinson's disease, multiple system atrophy, and Steele-Richardson-Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. Journal of Neurology, Neurosurgery & Psychiatry, 57, 278–284.
R. Ceravolo (2003). Dopaminergic degeneration and perfusional impairment in Lewy body dementia and Alzheimer's disease. Neurological Science, 24, 162–163.
G. El Fakhri (2006). Quantitative simultaneous (99m)Tc-ECD/123I-FP-CIT SPECT in Parkinson's disease and multiple system atrophy. European Journal of Nuclear Medicine and Molecular Imaging, 33, 87–92.
S. Gilman (2004). Striatal monoamine terminals in Lewy body dementia and Alzheimer's disease. Annals of Neurology, 55, 774–780.
J. Hort (2010). EFNS guidelines for the diagnosis and management of Alzheimer's disease. European Journal of Neurology, 17, 1236–1248.
X. S. Hu (2000). 18F-fluorodopa PET study of striatal dopamine uptake in the diagnosis of dementia with Lewy bodies. Neurology, 55, 1575–1577.
N. Kemppainen (2003). Hippocampal dopamine D2 receptors correlate with memory functions in Alzheimer's disease. European Journal of Neuroscience, 18, 149–154.
S. Klaffke (2006). Dopamine transporters, D2 receptors, and glucose metabolism in corticobasal degeneration. Movement Disorders, 21, 1724–1727.
R. A. Koeppe , S. Gilman , L. Junck , K. Wernette and K. A. Frey (2008). Differentiating Alzheimer's disease from dementia with Lewy bodies and Parkinson's disease with (+)-[11C]dihydrotetrabenazine positron emission tomography. Alzheimer's Dementia, 4, S67–S76.
S. Laureys (1999). Fluorodopa uptake and glucose metabolism in early stages of corticobasal degeneration. Journal of Neurology, 246, 1151–1158.
O. L. Lopez (2002). Research evaluation and prospective diagnosis of dementia with Lewy bodies. Archives of Neurology, 59, 43–46.
I. G. McKeith (2005). Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology, 65, 1863–1872.
I. McKeith (2007). Sensitivity and specificity of dopamine transporter imaging with 123I-FP-CIT SPECT in dementia with Lewy bodies: a phase III, multicentre study. Lancet Neurology, 6, 305–313.
A. R. Merdes (2003). Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies. Neurology, 60, 1586–1590.
P. T. Nelson (2010). Low sensitivity in clinical diagnoses of dementia with Lewy bodies. Journal of Neurology, 257, 359–366.
J. T. O'Brien (2004). Dopamine transporter loss visualized with FP-CIT SPECT in the differential diagnosis of dementia with Lewy bodies. Archives of Neurology, 61, 919–925.
J. T. O'Brien (2009). Diagnostic accuracy of 123I-FP-CIT SPECT in possible dementia with Lewy bodies. British Journal of Psychiatry, 194, 34–39.
F. Pasquier , F. Lebert , I. Lavenu and B. Guillaume (1999). The clinical picture of frontotemporal dementia: diagnosis and follow-up. Dementia & Geriatric Cognitive Disorders, 10 Suppl 1, 10–14.
M. A. Piggott (1999). Striatal dopaminergic markers in dementia with Lewy bodies, Alzheimer's and Parkinson's diseases: rostrocaudal distribution. Brain, 122 (Pt 8), 1449–1468.
O. Piguet , M. Hornberger , E. Mioshi and J. R. Hodges (2011). Behavioural-variant frontotemporal dementia: diagnosis, clinical staging, and management. Lancet Neurology, 10, 162–172.
G. Pizzolato (1996). Reduced striatal dopamine receptors in Alzheimer's disease: single photon emission tomography study with the D2 tracer [123I]-IBZM. Neurology, 47, 1065–1068.
M. Plotkin (2005). Combined 123I-FP-CIT and 123I-IBZM SPECT for the diagnosis of parkinsonian syndromes: study on 72 patients. Journal of Neural Transmission, 112, 677–692.
J. O. Rinne , M. Laine , V. Kaasinen , M. K. Norvasuo-Heila , K. Nagren and H. Helenius (2002). Striatal dopamine transporter and extrapyramidal symptoms in frontotemporal dementia. Neurology, 58, 1489–1493.
F. Sedaghat (2007). Evaluation of dopaminergic function in frontotemporal dementia using I-FP-CIT single photon emission computed tomography. Neurodegenerative Diseases, 4, 382–385.
M. Suzuki , T. J. Desmond , R. L. Albin and K. A. Frey (2002). Striatal monoaminergic terminals in Lewy body and Alzheimer's dementias. Annals of Neurology, 51, 767–771.
A. M. Vlaar (2008). Diagnostic value of 123I-ioflupane and 123I-iodobenzamide SPECT scans in 248 patients with parkinsonian syndromes. European Neurology, 59, 258–266.
R. W. Walker and Z. Walker (2009). Dopamine transporter single photon emission computerized tomography in the diagnosis of dementia with Lewy bodies. Movement Disorders, 24 Suppl 2, S754–S759.
Z. Walker , D. C. Costa , A. G. Janssen , R. W. Walker , G. Livingstone and C. L. Katona (1997). Dementia with lewy bodies: a study of post-synaptic dopaminergic receptors with iodine-123 iodobenzamide single-photon emission tomography. European Journal of Nuclear Medicine, 24, 609–614.
Z. Walker (2002). Differentiation of dementia with Lewy bodies from Alzheimer's disease using a dopaminergic presynaptic ligand. Journal of Neurology, Neurosurgery & Psychiatry, 73, 134–140.
Z. Walker (2007). Dementia with Lewy bodies: a comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. Journal of Neurology Neurosurgery & Psychiatry, 78, 1176–1181.
J. Zaccai , C. Brayne , I. McKeith , F. Matthews and P. G. Ince (2008). Patterns and stages of alpha-synucleinopathy: Relevance in a population-based cohort. Neurology, 70, 1042–1048.